Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GNAT2 encodes the cone photoreceptor-specific alpha subunit of transducin, a heterotrimeric G protein that plays a crucial role in the phototransduction cascade. This protein is specifically expressed in cone photoreceptors and is essential for color vision and daylight visual perception. The protein functions as part of a three-subunit guanine nucleotide-binding protein complex that mediates the coupling between rhodopsin and cGMP-phosphodiesterase during visual signal transduction. When light activates cone visual pigments, it induces GDP to GTP exchange at the guanosine-binding site of the transducin alpha subunit, leading to its release from inhibitory beta/gamma subunits. The activated GTP-transducin complex then binds and activates phosphodiesterase, which hydrolyzes cGMP, ultimately resulting in closure of cGMP-gated channels and membrane hyperpolarization. GNAT2 is located on chromosome 1p13 and comprises eight exons covering approximately 10 kb of genomic sequence. The encoded protein consists of 354 amino acid residues and shares 82% sequence identity with its rod photoreceptor paralog GNAT1. Mutations in GNAT2 are associated with achromatopsia 4, a rare autosomal recessive disorder characterized by complete color blindness, reduced visual acuity, photophobia, and nystagmus. However, GNAT2 mutations account for less than 2% of all achromatopsia cases, making it a minor achromatopsia locus compared to CNGA3 and CNGB3 genes. The protein is predicted to be located in cellular membranes and is active in the cytoplasm, photoreceptor inner segment, and photoreceptor outer segment. It demonstrates GTPase activity and is involved in G protein-coupled receptor binding, making it a critical component of the visual transduction machinery in cone photoreceptors.
G protein activation; Visual pigment coupling; Phosphodiesterase activation; cGMP hydrolysis regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein subunit alpha transducin 2 (GNAT2).